Depression May Raise Heart Failure RiskHuffington PostAn association was found between depression and heart failure; people with mild depression had a slightly increased risk of heart failure over that time period — just 5 percent. However, people wit…
|
FDA Grants “Breakthrough Therapy” Status for Gene Therapy to reduce Systolic …
Next Big Future Tweet Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases characterized by SERCA enzyme deficiencies, announced that its lead product candidate, … FDA grants breakthrough therapy status for Celladon’ heart failure treatment …Pharmaceutical Business Review |
The Chattanoogan |
Parkridge Medical Center Earns Quality Achievement Award For Heart Failure …
The Chattanoogan Parkridge Medical Center has received the Get With The Guidelines–Heart Failure Gold-Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American College of Cardiology … |
|
FDA grants breakthrough therapy status for Celladon’ heart failure treatment …
Pharmaceutical Business Review The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Celladon’s lead product candidate, Mydicar, for reducing hospitalisations for heart failure in NYHA class III or IV chronic heart failure patients who are NAb … FDA Grants “Breakthrough Therapy” Status for Gene Therapy to reduce Systolic …Next Big Future |
|
New Prediction Model To Improve Patient Survival After Paracetamol-Related …
RedOrbit … “Acute liver failure is a devastating condition that triggers a cascade of events that can lead to multiple organ failure and often death.” “This high-performance survival model for paracetamol-induced acute liver failure will enable each … Novel prediction model improves patient outcomes after paracetamol-induced …News-Medical.net |
|
Optimism associated with lower risk of heart failure, study says
Times of India MUMBAI: Researchers from the University of Michigan and Harvard University found that optimism — an expectation that good things will happen — among people age 50 and older significantly reduced their risk of heart failure. Compared to the least … |
Drug a dud for diastolic heart failureScienceBlog.com (blog)A drug that blocks the action of a key hormone did not significantly improve a set of cardiovascular outcomes for patients with diastolic heart failure, a condition in which the heart is stiff…
Tasnim News Agency |
Depression Raises Risk of Heart Failure by 40 Percent
Tasnim News Agency “We found a dose response relationship between depressive symptoms and the risk of developing heart failure. That means that the more depressed you feel, the more you are at risk,” Lise Tuset Gustad, first author of the study and an intensive care … |
|
Celladon Receives Breakthrough Therapy Designation From FDA for MYDICAR …
GlobeNewswire (press release) SAN DIEGO, April 10, 2014 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases characterized by SERCA enzyme deficiencies, … Celladon Gets FDA’s “Breakthrough Therapy” Status for Gene TherapyXconomy Celladon Gets Breakthrough Therapy Designation For Mydicar From FDARTT News |
2 Minute MedicineDrug does not improve set of cardiovascular outcomes for diastolic heart failureNational Institutes of Health (press release)A drug that blocks the action of a key hormone did not significantly improve a set of cardiovascular outcomes …